Abstract: Methods, apparatus, and processor-readable storage media for protecting data based on a context of data movement operations are provided herein. An example computer-implemented method includes obtaining a list of carriers in response to a request to transfer data, stored on a storage system associated with a first location, to a second location, wherein each of the carriers is configured to physically move at least one mobile storage unit; scheduling at least two of the carriers to perform the transfer; transferring at least a portion of the data as data chunks from the first location to the second location, wherein each of the scheduled carriers transfers different data chunks via the corresponding at least one mobile storage unit; and transferring, over a network, at least one of: control information corresponding to the transfer and at least another portion of the data associated with the request.

Abstract: Methods, apparatus, and processor-readable storage media for protecting data based on a context of data movement operations are provided herein. An example computer-implemented method includes obtaining a list of carriers in response to a request to transfer data, stored on a storage system associated with a first location, to a second location, wherein each of the carriers is configured to physically move at least one mobile storage unit; scheduling at least two of the carriers to perform the transfer; transferring at least a portion of the data as data chunks from the first location to the second location, wherein each of the scheduled carriers transfers different data chunks via the corresponding at least one mobile storage unit; and transferring, over a network, at least one of: control information corresponding to the transfer and at least another portion of the data associated with the request.

Abstract: A utility cart includes a stored energy device that can be in the form of a Lithium Ion battery pack. The battery pack can include a main power output useful to drive high voltage components as well as the electric motor for motive power. The battery pack can also include one or more auxiliary outputs useful to provide auxiliary power to various other components. The auxiliary outputs can be either low and/or high voltage outputs. An auxiliary DC/DC output can be used to step down high voltage of the Lithium ion battery pack to lower voltages. A motor controller supply can also be provided as an auxiliary output to provide some power to a motor controller.

Abstract: The present invention is directed to the prevention of EMF wave damage to the cells of dogs and cats. The invention features a Tachyon infused collar that may comprise a base strip with webbing material. The collar with a remediation energy converts chaotic EMF waves into non-damaging waves. Alternatively, the webbing material may be infused with a combination of Tachyon and shungite as further enhancement of the invention. In another embodiment, filler material for a bed or pillow for a dog or cat is infused with Tachyon or a combination of Tachyon and shungite.

Abstract: A utility vehicle includes an electric motor constructed to provide motive power to the utility vehicle; a lithium ion battery pack coupled to the electric motor at a first voltage and operative to provide electrical power at the first voltage to the electric motor for driving the utility vehicle, the lithium ion battery pack including a DC/DC converter constructed to output electrical power at a second voltage; and a vehicle control module (VCM) coupled to the DC/DC converter, constructed to operate at the second voltage and constructed to control at least some operations of the utility vehicle.

Abstract: A utility cart includes a stored energy device that can be in the form of a Lithium Ion battery pack. The battery pack can include a main power output useful to drive high voltage components as well as the electric motor for motive power. The battery pack can also include one or more auxiliary outputs useful to provide auxiliary power to various other components. The auxiliary outputs can be either low and/or high voltage outputs. An auxiliary DC/DC output can be used to step down high voltage of the Lithium ion battery pack to lower voltages. A motor controller supply can also be provided as an auxiliary output to provide some power to a motor controller.

Abstract: A utility vehicle includes an electric motor constructed to provide motive power to the utility vehicle; a lithium ion battery pack coupled to the electric motor at a first voltage and operative to provide electrical power at the first voltage to the electric motor for driving the utility vehicle, the lithium ion battery pack including a DC/DC converter constructed to output electrical power at a second voltage; and a vehicle control module (VCM) coupled to the DC/DC converter, constructed to operate at the second voltage and constructed to control at least some operations of the utility vehicle.

Abstract: An improved healthcare service includes a patient device adapted to provide interfaces for indicating whether a procedure is inpatient, entering codes and prices for the procedure, asking questions of the patient, create a payment summary, generate a payment, editing procedure descriptions, listing pending procedures and providers that can perform procedures, and displaying prices of services of a selected provider; a doctor device adapted to provide interfaces for displaying a listing of procedures of patients of a doctor; posting the doctor's available services and schedules; editing the doctor's specialty; posting needs for facilities and specialists; viewing incoming requests for services; searching for and communicating with facilities and specialists; and a server adapted to provide databases for storing information communicated between the patient and doctor device, provider information, information regarding diagnosis related groups of procedures, and information regarding procedure pricing; and deter

Abstract: A process for producing phenol and methyl ethyl ketone comprises contacting benzene with a C4 alkylating agent under alkylation conditions with catalyst comprising zeolite beta or a molecular sieve having an X-ray diffraction pattern including d-spacing maxima at 12.4±0.25, 6.9±0.15, 3.57±0.07 and 3.42±0.07 Angstrom to produce an alkylation effluent comprising sec-butylbenzene. The sec-butylbenzene is then oxidized to produce a hydroperoxide and the hydroperoxide is decomposed to produce phenol and methyl ethyl ketone.

Abstract: This invention relates to conjugates of the Vi polysaccharide of S. typhi with the carrier Pseudomonas aeruginosa recombinant exoprotein A (rEPA), and compositions thereof, and to methods of using of these conjugates and/or compositions thereof for eliciting an immunogenic response in humans, including responses which provide protection against, or reduce the severity of, S. typhi bacterial infections. The conjugates, and compositions thereof, are useful as vaccines to induce serum antibodies against S. typhi and are useful to prevent and/or treat illnesses caused by S. typhi.

Abstract: The disclosure pertains to conjugates of the capsular polysaccharide of Vibrio cholerae O139, or a structurally and/or immunologically related oligo- or poly-saccharide, and a carrier. These conjugates are useful as pharmaceutical compositions and/or vaccines to induce serum antibodies which have bactericidal (vibriocidal) activity against V. cholerae, in particular V. cholerae O139, and are useful to prevent, treat and/or reduce the severity of disease caused by V. cholerae infection, such as cholera. The present disclosure also relates to diagnostic tests for V. cholerae infection, and/or cholera caused by V. cholerae infection, using one or more of the oligo- or poly-saccharide-carrier conjugates or antibodies described above.

Abstract: A computer system for facilitating payments from an account according to particular embodiments of the invention is adapted for: (1) facilitating the transmission, to a plan service provider, of a first set of documentation of a first payment that would potentially qualify for reimbursement from the account; (2) receiving, from the plan service provider, verification that the first payment has been verified as qualifying for reimbursement from the account according to a set of reimbursement rules associated with the account; (3) storing, in memory, an electronic version of the first set of documentation; and (4) storing, in memory, an indication that the first payment has been verified as being properly reimbursable from the account.

Abstract: A computer system according to particular embodiments of the invention is adapted for: (A) receiving one or more claims for reimbursement from an account holder of a health savings account; (B) after receiving the one or more claims, allowing a plan service provider to: (1) review each particular one of the one or more claims for reimbursement to determine whether the particular claim is properly reimbursable from the health savings account; and (2) in response to determining that the particular claim is reimbursable from the health savings account, certify that the particular claim is properly reimbursable from the health savings account.

Abstract: Unique compounds that can be used for inducing an immune response to Borrelia burgdorferi in a subject by administering a therapeutically effective amount of the glycolipid to the subject. Such administration is particularly useful for preventing or treating Lyme disease in a subject. The compounds(s), and therapeutically acceptable salts thereof, may be formulated into pharmaceutical or immunogenic compositions.

Abstract: Immunogenic compositions and methods for eliciting an immune response against B. anthracis and other bacilli are provided that include immunogenic conjugates of a poly-?-glutamic acid (?PGA) polypeptide of B. anthracis, or of another Bacillus that expresses a ?PGA polypeptide. The ?PGA conjugates elicit an effective immune response against B. anthracis, or against another Bacillus, in mammalian hosts to which the conjugates are administered.

Abstract: The present invention includes a fuel cell system and a method to operate a fuel cell. The fuel cell system includes a source of a fuel and water emulsion, receiving the emulsion and a reformer for receiving the emulsion and producing hydrogen, a hydrogen-oxygen fuel cell connected to the reformer and able to receive hydrogen from the reformer. The method for operating a fuel cell system including a hydrogen gas oxygen fuel cell includes producing the hydrogen gas from a fuel and water emulsion.

Abstract: Methods for making an immunogenic conjugate that includes a hapten or an antigen covalently linked to a carrier. The methods include reacting a first agent with a dihydrazide resulting in a hydrazino-modified first agent, wherein the first agent is a hapten, an antigen or a carrier; reacting a second agent with a benzaldehyde compound resulting in a benzaldehyde-modified second agent, wherein the second agent is a hapten, an antigen or a carrier, provided that the first agent or the second agent is a carrier; and reacting the hydrazine-modified first agent with the benzaldehyde-modified second agent resulting in an immunogenic conjugate comprising a hapten or an antigen covalently linked to a carrier via a hydrazone linkage.

Abstract: The present invention provides for immunogenic compositions and their methods of use as vaccines and their method of preparation. These immunogenic compositions comprise a recombinant protein of toxin A or toxin B of Clostridium difficile conjugated to a polysaccharide of a microbial pathogen. The immunogenic compositions may include only a truncated portion of toxin A or toxin B, particularly the repeating units (rARU or rBRU), that is associated with a microbial pathogen polysaccharide. Such compositions are effective in eliciting T-cell dependent and antibody responses. These compositions are therefore effective as vaccines for humans, particularly children, and animals in affording protection against one or more microbial pathogens.

Abstract: The present invention relates, e.g., to a glycoconjugate composition comprising one or more polysaccharide types from a cell wall polysaccharide preparation from B. pumilus Sh 18, or variants thereof. Also disclosed are antibodies generated against the glycoconjugates, and methods of using the glycoconjugates and antibodies. An antimultiorganism vaccine which reacts against at least Haemophilus influenzae type a, Haemophilus influenzae type b, Staphylococcus aureus, and Staphylococcus epidermidis, is disclosed.

Abstract: This invention relates to conjugates of the O-specific polysaccharide of E. coli O157 with a carrier, and compositions thereof, and to methods of using of using of these conjugates and/or compositions thereof for eliciting an immunogenic response in mammals, including responses which provide protection against, or reduce the severity of, bacterial infections. More particularly it relates to the use of polysaccharides containing the tetrasaccharide repeat unit: (?3)-?-DGalpNAc-(1?2)-?-D-PerpNAc-(1?3)-?-L-Fucp-(1?4)-?-D-Glcp-(1?), and conjugates thereof, to induce serum antibodies having bactericidal (killing) activity against hemolytic-uremic syndrome (HUS) causing E. coli, in particular E. coli O157. The conjugates, and compositions thereof, are useful as vaccines to induce serum antibodies which have bactericidal or bacteriostatic activity against E. coli, in particular E. coli O157, and are useful to prevent and/or treat illnesses caused by E. coli O157.